# Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate

> **NCT04598620** · — · COMPLETED · sponsor: **Inger Lise Gade** · enrollment: 28 (actual)

## Conditions studied

- Covid19
- Corona Virus Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04598620
- **Lead sponsor:** Inger Lise Gade
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-19
- **Primary completion:** 2021-10-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04598620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04598620, "Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04598620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*